Sun PharmaThese bicalutamide tablets, USP 50 milligram are therapeutically equivalent to Casodex tablets from AstraZeneca Casodex tablets have annual sales of approximately $314 million in the US.

Bicalutamide tablets are an androgen receptor inhibitor indicated for use in combination therapy with a lutenizing harmone-releasing harmone (LHRH) analog for treatment of stage D2 metastatic carcinoma of the prostate.